KYMR - Kymera Therapeutics, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.77
|
Rev Est: $14.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$117.25
DETAILS
HIGH:
$138.00
LOW:
$90.00
MEDIAN:
$119.00
CONSENSUS:
$117.25
UPSIDE:
28.83%
Market Cap:
7.19B
Volume:
820,887
Avg Volume:
989,924
52 Week Range:
19.445-103
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.26
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
208
IPO Date:
2020-08-21
EPS (TTM):
-2.98
P/E Ratio:
-13.49
Revenue (TTM):
47.07M
Total Assets:
978.03M
Total Debt:
87.76M
Cash & Equiv:
120.26M
Rev Growth (5Y):
74.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-24.6%
Debt/Equity:
0.11
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $-0.90 | $-0.71 | -26.8% | $2.8M | $14.5M | -80.9% |
| 2025-08-11 | $-0.95 | $-0.83 | -14.5% | $11.5M | $17.1M | -33.0% |
| 2025-05-09 | $-0.82 | $-0.92 | +10.9% | $22.1M | $12.4M | +78.5% |
| 2025-02-27 | $-0.88 | $-0.76 | -15.8% | $7.4M | $16.7M | -55.7% |
| 2024-10-31 | $-0.82 | $-0.83 | +1.2% | $3.7M | $15.2M | -75.4% |
| 2024-08-07 | $-0.58 | $-0.69 | +15.9% | $25.6M | $12.6M | +104.4% |
| 2024-05-02 | $-0.69 | $-0.73 | +5.5% | $10.3M | $13.7M | -24.9% |
| 2024-02-22 | $-0.25 | $-0.44 | +43.2% | $47.9M | $42.0M | +14.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 47.07M | 78.59M | 46.83M | 72.83M | 34.03M | 2.93M | 0 |
| Net Income | (223.86M) | (146.96M) | (154.81M) | (100.22M) | (45.59M) | (41.29M) | (21.47M) |
| EPS | -2.98 | -2.52 | -2.87 | -2.09 | -0.99 | -0.93 | -0.48 |
| Total Assets | 978.03M | 575.76M | 603.13M | 605.90M | 487.18M | 116.70M | 44.23M |
| Total Debt | 87.76M | 84.67M | 17.34M | 17.96M | 17.99M | 21.19M | 695,000 |
| Cash & Equivalents | 120.26M | 109.97M | 68.39M | 47.98M | 31.00M | 76.02M | 41.26M |
| Operating Cash Flow | (194.50M) | (102.83M) | (153.09M) | (128.95M) | 88.13M | 17.91M | (17.86M) |
| Free Cash Flow | (207.34M) | (137.31M) | (155.92M) | (130.54M) | 79.03M | 17.37M | (19.22M) |
| FCF per Share | -2.76 | -2.35 | -2.89 | -2.72 | 1.77 | 0.39 | -0.43 |
| Book Value | 835.62M | 394.97M | 490.15M | 459.64M | 283.89M | (74.41M) | (34.44M) |
| Cash & ST Investments | 488.74M | 374.88M | 407.17M | 442.42M | 296.20M | 91.96M | 41.26M |
| ROC Equity | -0.27 | -0.37 | -0.32 | -0.22 | -0.16 | N/A | N/A |